Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10764760rdf:typepubmed:Citationlld:pubmed
pubmed-article:10764760lifeskim:mentionsumls-concept:C0019704lld:lifeskim
pubmed-article:10764760lifeskim:mentionsumls-concept:C0085828lld:lifeskim
pubmed-article:10764760lifeskim:mentionsumls-concept:C1444754lld:lifeskim
pubmed-article:10764760lifeskim:mentionsumls-concept:C0040624lld:lifeskim
pubmed-article:10764760lifeskim:mentionsumls-concept:C0005456lld:lifeskim
pubmed-article:10764760lifeskim:mentionsumls-concept:C1519249lld:lifeskim
pubmed-article:10764760lifeskim:mentionsumls-concept:C0023978lld:lifeskim
pubmed-article:10764760lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:10764760lifeskim:mentionsumls-concept:C1621396lld:lifeskim
pubmed-article:10764760lifeskim:mentionsumls-concept:C1882417lld:lifeskim
pubmed-article:10764760lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:10764760lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:10764760lifeskim:mentionsumls-concept:C0332183lld:lifeskim
pubmed-article:10764760pubmed:issue27lld:pubmed
pubmed-article:10764760pubmed:dateCreated2000-8-16lld:pubmed
pubmed-article:10764760pubmed:abstractTextTo study the role of MAPK cascades in the regulation of naturally occurring human immunodeficiency virus type 1 long terminal repeats (HIV-1 LTRs), we analyzed several HIV-1 LTRs from patients at different stages of disease progression. One of these naturally occurring HIV-1 LTRs contains an insertion termed the most frequent naturally occurring length polymorphism (MFNLP) and exhibited high inducibility upon T cell activation. We found that the protein kinase mixed lineage kinase 3/src-homology 3 domain-containing proline-rich kinase, a specific activator of the stress-activated protein kinase (SAPK)/JNK signaling pathway in T lymphocytes, induces high transcriptional activation of this promoter. Promoter inducibility is inhibited by the SAPK/JNK inhibitor, the JNK binding domain of the JNK interacting protein 1, and Tam-67 (N-terminal deletion mutant of c-Jun). In electrophoretic mobility shift assay, several protein complexes were found to bind to the MFNLP sequence in T cells. We identified AP-1 factors c-Fos and JunB as MFNLP-binding proteins, whose binding is abolished by introducing point mutations in the 3'-half of the MFNLP sequence. Introduction of these point mutations into the MFNLP containing HIV-1 LTR reduced src-homology 3 domain-containing proline-rich kinase -mediated transactivation. These data indicate that the AP-1-like binding site in the MFNLP sequence gives rise to a higher inducibility of natural HIV-LTRs by the SAPK/JNK signaling pathway.lld:pubmed
pubmed-article:10764760pubmed:languageenglld:pubmed
pubmed-article:10764760pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10764760pubmed:citationSubsetIMlld:pubmed
pubmed-article:10764760pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10764760pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10764760pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10764760pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10764760pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10764760pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10764760pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10764760pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10764760pubmed:statusMEDLINElld:pubmed
pubmed-article:10764760pubmed:monthJullld:pubmed
pubmed-article:10764760pubmed:issn0021-9258lld:pubmed
pubmed-article:10764760pubmed:authorpubmed-author:RappU RURlld:pubmed
pubmed-article:10764760pubmed:authorpubmed-author:ChenPPlld:pubmed
pubmed-article:10764760pubmed:authorpubmed-author:LudwigSSlld:pubmed
pubmed-article:10764760pubmed:authorpubmed-author:FloroSSlld:pubmed
pubmed-article:10764760pubmed:authorpubmed-author:KirchhoffFFlld:pubmed
pubmed-article:10764760pubmed:authorpubmed-author:AvotsAAlld:pubmed
pubmed-article:10764760pubmed:authorpubmed-author:JordanB WBWlld:pubmed
pubmed-article:10764760pubmed:issnTypePrintlld:pubmed
pubmed-article:10764760pubmed:day7lld:pubmed
pubmed-article:10764760pubmed:volume275lld:pubmed
pubmed-article:10764760pubmed:ownerNLMlld:pubmed
pubmed-article:10764760pubmed:authorsCompleteYlld:pubmed
pubmed-article:10764760pubmed:pagination20382-90lld:pubmed
pubmed-article:10764760pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:10764760pubmed:meshHeadingpubmed-meshheading:10764760...lld:pubmed
pubmed-article:10764760pubmed:meshHeadingpubmed-meshheading:10764760...lld:pubmed
pubmed-article:10764760pubmed:meshHeadingpubmed-meshheading:10764760...lld:pubmed
pubmed-article:10764760pubmed:meshHeadingpubmed-meshheading:10764760...lld:pubmed
pubmed-article:10764760pubmed:meshHeadingpubmed-meshheading:10764760...lld:pubmed
pubmed-article:10764760pubmed:meshHeadingpubmed-meshheading:10764760...lld:pubmed
pubmed-article:10764760pubmed:meshHeadingpubmed-meshheading:10764760...lld:pubmed
pubmed-article:10764760pubmed:meshHeadingpubmed-meshheading:10764760...lld:pubmed
pubmed-article:10764760pubmed:meshHeadingpubmed-meshheading:10764760...lld:pubmed
pubmed-article:10764760pubmed:meshHeadingpubmed-meshheading:10764760...lld:pubmed
pubmed-article:10764760pubmed:meshHeadingpubmed-meshheading:10764760...lld:pubmed
pubmed-article:10764760pubmed:meshHeadingpubmed-meshheading:10764760...lld:pubmed
pubmed-article:10764760pubmed:meshHeadingpubmed-meshheading:10764760...lld:pubmed
pubmed-article:10764760pubmed:meshHeadingpubmed-meshheading:10764760...lld:pubmed
pubmed-article:10764760pubmed:meshHeadingpubmed-meshheading:10764760...lld:pubmed
pubmed-article:10764760pubmed:meshHeadingpubmed-meshheading:10764760...lld:pubmed
pubmed-article:10764760pubmed:meshHeadingpubmed-meshheading:10764760...lld:pubmed
pubmed-article:10764760pubmed:meshHeadingpubmed-meshheading:10764760...lld:pubmed
pubmed-article:10764760pubmed:year2000lld:pubmed
pubmed-article:10764760pubmed:articleTitleTransactivation of naturally occurring HIV-1 long terminal repeats by the JNK signaling pathway. The most frequent naturally occurring length polymorphism sequence introduces a novel binding site for AP-1 factors.lld:pubmed
pubmed-article:10764760pubmed:affiliationInstitut für Medizinische Strahlenkunde und Zellforschung, Universität Würzburg, Versbacher Strasse 5, D-97078 Würzburg, Germany.lld:pubmed
pubmed-article:10764760pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10764760pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:2353entrezgene:pubmedpubmed-article:10764760lld:entrezgene
entrez-gene:3726entrezgene:pubmedpubmed-article:10764760lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:10764760lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10764760lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10764760lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10764760lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10764760lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10764760lld:pubmed